Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products
The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide.
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold.
Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Shareholders of Tilray would probably like to forget the past six months even happened. The stock dropped 54.1% and now trades at $0.87. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Tilray Brands stock is trading lower on Monday, alongside other cannabis-related stocks, following President Donald Trump's announcement of new tariffs on imported goods from Canada, Mexico and China, set to take effect Tuesday.
